With Vitruvian Shield, we developed a 24/7 e-health monitoring solution, which will provide your doctor with detailed reports about a patient's physical condition (cardiac rate, sleep activity, stress levels) as well as keeping track of their seizures and what may trigger them so a more effective treatment is performed.
Epilepsy is the 4th most common serious brain disorder worldwide, currently affecting more than 6 million people in Europe alone.
Thanks to medication, about 2 in every 3 people stop having seizures, while for the others' epilepsy is unrestrained by treatment, which may lead to SUDEP (Sudden Unexpected Death in Epilepsy).
Vitruvian Shield partners with
Centre Hospitalier Universitaire Vaudois
Haute École Neuchâtel Berne Jura
Our partners help us to develop an excelent product
Check out our full list of partners